Search result for 'pharmaceutical market'

India and Uzbekistan discussed strengthening pharma safety and quality, including developing pharmacovigilance and preventing counterfeit drugs. The meeting took place during the 19th International...

India's pharma sector, valued at USD 50 billion, is projected to reach USD 130 billion by 2030. Economic Survey highlights the need for skill development, innovation, and a robust supply chain for...

Torrent Pharmaceuticals has licensed Vonoprazan, a novel P-CAB for GERD treatment, from Takeda. The drug will be marketed in India under the brand name Kabvie.

Sun Pharma expects high single-digit top line growth in the current fiscal, driven by investments in product launches and R&D. The company is aiming for continued growth in its global...

French drugmaker Sanofi aims for a larger share of the Indian market, introducing new drugs, localizing production, and partnering with domestic firms to expand its reach.

Orchid Pharma has received USFDA approval for Enmetazobactam, a new drug to treat complicated urinary tract infections. This marks a significant development in addressing global antimicrobial...

Venus Remedies has received marketing authorisation from Philippines and Saudi Arabia for three oncology drugs, expanding its reach in Southeast Asia and the Middle East.